Dhanny Primantara Johari Santoso

Dhanny Primantara Johari Santoso

Auto-generated profile, based on publicly available information

Dhanny Primantara Johari Santoso

Slamet District Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2023 in Medical Science Monitor
Verified
Journal Article
Open access
APAdhi Pribadi
Adhi Pribadi
DHDini Hidayat
Dini Hidayat
RSR.M. Sonny Sasotya
R.M. Sonny Sasotya
MAMuhammad Alamsyah Aziz
Muhammad Alamsyah Aziz
WNWindi Nurdiawan
Windi Nurdiawan
WPWiryawan Permadi
Wiryawan Permadi
The Zero Mother Mortality Preeclampsia (ZOOM) program was adopted as an accelerated initiative to curb mortality related to hypertensive disorders in pregnancy, including preeclampsia. This single-center, retrospective study in Bandung, West Java, aims to evaluate the impact of the ZOOM program implemented from 2015 to 2022. We analyzed 19,176 childbirths and associated maternal deaths due to hypertension in pregnancy. Diagnoses were validated using blood pressure measures, lab tests including urine protein, liver function, blood profiles, platelets, X-ray, echocardiography, and COVID-19 testing. The case fatality rate (CFR) was assessed to evaluate the impact of the ZOOM program. Hypertension in pregnancy was identified in 25.1% of cases, with 9.8% and 1.4% attributed to preeclampsia and eclampsia, respectively. Maternal deaths associated with hypertension accounted for 36.6%, with the majority linked to eclampsia. Heart failure (45.5%) and Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome (22%) were the most common complications. The CFR decreased from 61% in 2018 to 10% in 2022. The overall CFR from 2015 to 2022 was 1.3%, with the highest fatality rate observed in eclampsia cases (9.4%). However, a declining trend was seen since 2018, reaching a low of 0.2% in 2021. The implementation of the ZOOM program, which includes preeclampsia re-education, early detection, prompt intervention, protocol adjustments, and a refined referral system, led to a marked reduction in maternal deaths from hypertensive pregnancy disorders.

14 March 2024 in Medical Science Monitor
Verified
Journal Article
Open access
MAMuhammad Alamsyah Aziz
Muhammad Alamsyah Aziz
DHDini Hidayat
Dini Hidayat
GIGiritama Irwantoro
Giritama Irwantoro
ANAnnisa Dewi Nugrahani
Annisa Dewi Nugrahani
JWJeffri Januar Wijaya
Jeffri Januar Wijaya
SKSofie Rifayani Krisnadi
Sofie Rifayani Krisnadi
BACKGROUND Preterm birth is one of the main causes of neonatal death worldwide. One strategy focused on preventing preterm birth is the administration of long chain polyunsaturated fatty acids (LCPUFAs) during pregnancy. Omega-3 LCPUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are essential in metabolic and physiological processes during embryonic and fetal development. This study aimed to compare DHA and EPA levels in 44 women with preterm births and 44 women with term births at a tertiary hospital in West Java Province, Indonesia, between November 2022 and March 2023. MATERIAL AND METHODS A total of 88 patients in this study consisted of 44 patients with term births (≥37 gestational weeks) and 44 patients with preterm births (<37 gestational weeks) at a tertiary hospital in West Java Province, Indonesia. This observational, cross-sectional study was conducted from November 2022 to March 2023. Using the enzyme-linked immunosorbent assay test, maternal DHA and EPA levels were investigated. IBM SPSS 24.0 was used to statistically measure outcomes. RESULTS Average maternal DHA and EPA levels in patients with preterm births were significantly lower than those in term births. Preterm labor risk was further increased by DHA levels of ≤5.70 µg/mL (OR=441.00, P=0.000) and EPA levels ≤3971.54 µg/mL (OR=441.00, P=0.000). CONCLUSIONS Since the average maternal DHA and EPA levels were significantly lower in patients with preterm births, adequate intake of omega-3 LCPUFA in early pregnancy and consistency with existing nutritional guidelines was associated with a lower risk of preterm delivery for pregnant women.

11 September 2023 in American Journal of Case Reports
Verified
Journal Article
Open access
APAdhi Pribadi
Adhi Pribadi
ASAmillia Siddiq
Amillia Siddiq
ANAnnisa Dewi Nugrahani
Annisa Dewi Nugrahani
DSDhanny Primantara Johari Santoso
Dhanny Primantara Johari Santoso
BACKGROUND Hypoplastic left heart syndrome (HLHS) is a complex left-sided obstructive congenital cardiac condition with several variants. This report is of 5 cases with varying morphology of HLHS diagnosed by fetal prenatal ultrasound at the 4-chamber view (4CV) level. CASE REPORT Five cases were referred by obstetrics and gynecology specialists with preliminary information on visible congenital abnormalities in the third trimester. Fetal echocardiography showed that several morphological variants of HLHS were found. The patient in the first case had the most frequently found variant; this variation is usually linked to mitral valve stenosis (MVS). The second case had the characteristic of mitral valve atresia (MVA), and as a consequence, blood flow was not visible in this variant and the left ventricle (LV) was not clear or not adequately visualized by ultrasound. In the third case, the patient suffered from severe MVS and perhaps a small aorta. Uni-atrial conditions were described in the third case. In the fourth case, the patient had a narrow LV, MVA, ventricular septal defect, nearly united atrium, and tricuspid regurgitation. The fifth case was a case of HLHS with congenital diaphragmatic hernia. Further, 4 out of 5 of the cases were associated with widening of the cisterna magna and Dandy Walker syndrome-associated posterior fossa disorder malformations. The overall maternal age was over 35 years old in 4 cases. Karyotyping examination was not performed in all cases. CONCLUSIONS The role of ultrasound is very important in determining the diagnosis and the degree of development of hypoplastic LV. However, visualization at the 4CV level can detect abnormalities found in the LV.

14 August 2023 in Medical Science Monitor
Verified
Journal Article
Open access
AAAnita Deborah Anwar
Anita Deborah Anwar
ANAnnisa Dewi Nugrahani
Annisa Dewi Nugrahani
DSDhanny Primantara Johari Santoso
Dhanny Primantara Johari Santoso
MAMuhammad Alamsyah Aziz
Muhammad Alamsyah Aziz
LULia Ulfah
Lia Ulfah
ASAsep Surachman
Asep Surachman
Background: Hepatitis B virus (HBV) infection during pregnancy is a significant concern due to the risk of vertical transmis-sion to the newborn, posing serious health complications. Understanding the effectiveness of intervention pro-grams is paramount, especially in regions where comprehensive research is sparse. This study delves into the efficacy of the HBV elimination program in Garut Regency, West Java, Indonesia, targeting pregnant women and their newborns.Material/Methods: This cross-sectional research encompassed 100 HBsAg-positive pregnant women who delivered at a singular facility in Garut Regency and their 62 offspring. Clinical data collection was rigorous, and HBsAg status was determined using rapid test kits, employing the precision of the 2-sided sandwich assay immunochromatogra-phy method. Data interpretation was multifaceted, involving univariate, bivariate, and multiple regression lo-gistic analyses.Results: Notably, 16.95% of women, previously diagnosed as HBsAg-negative by initial health assessments, were subse-quently diagnosed as positive at the specialized referral hospital. A noteworthy finding was that children admin-istered with the HBV vaccine manifested a significantly diminished Positive-HBsAg status (P=0.029). Intriguingly, a majority of the maternal variables displayed a direct correlation with the HBsAg status of their offspring. The protective role of the HBV vaccine against HBV infection stood out distinctly (OR=0.326; CI 0.019-5.554; P=0.029). Conclusions: While our center successfully met the desired HBsAg testing coverage in pregnant women, the administration of the hepatitis B vaccine to infants born to HBsAg-positive mothers lags behind the intended target. Emphasizing the vaccination's vital role, our study underscores its significance as a frontline defense for such infants.

10 January 2025 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
ASA. Z. Suryawan
A. Z. Suryawan
ANA. Sh. Nisa
A. Sh. Nisa
DSD.P.J. Santoso
D.P.J. Santoso
SSS. A. Slamet
S. A. Slamet
BHB. Handono
B. Handono
In Indonesia, thiamine (B1) has been use for cervical priming and enhancing uterine contraction in midwife and hospital setting as its off-label effect. However there are no clear evidence and research related to this issue. Thiamine itself was founded in 1990’s and has been used extensively as labour augmentation in 1940–1960’s. Main hypothesis previously due to B1 increased function of the uterine body and lower uterine segment obliteration during labour which also responsible for the reduction of pain. Thiamine also assumed to promote stimulation of uterine contractions by direct participation in nerve impulses that regulates and establish the rhythm of uterine contractions and also inhibits action of cholinesterase which reduce acetylcholine clearance. However recent research proves B1 mainly function in Krebs cycle specifically in decarboxylase of pyruvate to acetyl-CoA in form of thiamin diphosphate, synonymously known as thiamine pyrophosphate. Due to clear foundings of B1 function in cell energy metabolism, study of B1 in labour augmentation was not continue further. It’s also related to uterine contraction function in labour not relied on it’s paracervical parasympathetic ganglia which respond to acetylcholine but rely heavily on oxytocin and its receptor. As conclusion, the author stated B1 have no effect on labour progression however could prove beneficial if the mother has B1 deficiency as it’s could reduce energy output from cell which could affect myometrial contraction.

15 January 2022 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
DSDhanny Primantara Johari Santoso
Dhanny Primantara Johari Santoso
BPBenny Hasan Purwara
Benny Hasan Purwara
EAEppy Darmadi Achmad
Eppy Darmadi Achmad
Objective This study aimed to analyze the correlation between the immunoexpression of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TiMP1) in the uterosacral ligaments in patients with uterine prolapse. Methods This analytic-correlative cross-sectional study included 32 patients who were admitted at the Hasan Sadikin General Hospital from July to December 2013. Sixteen of the patients had uterine prolapse, while the rest did not. The patients underwent total hysterectomy, radical hysterectomy, or staging laparotomy. MMP-9 and TiMP1 expression in the uterosacral ligaments was measured via immunohistochemical staining. The median expression per field of view was calculated using a histoscore. Results MMP-9 expression in patients with uterine prolapse was found to be higher than that in the control group. Meanwhile, TiMP1 expression showed no significant difference between the groups. Spearman’s analysis showed a moderate correlation between the expression of MMP-9 and uterine prolapse incidence (P=0.02), with a correlation coefficient of 0.574. Conclusion There is a moderate correlation between MMP-9 expression and the incidence of uterine prolapse. It can be considered one of the primary etiologies of uterine prolapse.